Michael D Magill

Title: Michael D. Magill: Innovator in Sentinel Node Identification

Introduction

Michael D. Magill is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of medical technology, particularly in the identification of sentinel lymph nodes. His innovative approach has the potential to enhance surgical outcomes for patients with neoplastic tissue.

Latest Patents

Magill holds a patent for a radiation-based method for locating and differentiating sentinel nodes. This method involves injecting a radiopharmaceutical at the site of neoplastic tissue, which then migrates along a lymph duct toward the drainage basin containing the sentinel node. A hand-held probe equipped with a radiation detector is used to identify the sentinel node by monitoring count rate amplitudes. The technique allows clinicians to accurately locate and remove the sentinel node during surgery.

Career Highlights

Michael D. Magill has dedicated his career to advancing medical technology. His work at Neoprobe Corporation has been instrumental in developing innovative solutions for lymphatic mapping. With a patent portfolio that includes 1 patent, he continues to push the boundaries of what is possible in the medical field.

Collaborations

Throughout his career, Magill has collaborated with esteemed colleagues such as Marlin O. Thurston and Karl W. Olson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Michael D. Magill's contributions to the field of medical technology, particularly in sentinel node identification, demonstrate his commitment to improving patient care. His innovative methods and collaborative spirit continue to inspire advancements in the medical community.